Evidence map›Paper›PMID 31966890›Full record

ArticleInternational journal of clinical and experimental pathology2017

The association of inhibitor of Growth 4 with its prognostic value in osteogenic sarcoma.

Fengguo Li, Jianhua Sun, Bin Liu, Xinhu Zhang, Lianjun Zhou, Jutao Pang

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fengguo LiThird Department of Orthopedics, Harrison International Peace Hospital Hengshui, Hebei, China.
Jianhua SunThird Department of Orthopedics, Harrison International Peace Hospital Hengshui, Hebei, China.
Bin LiuThird Department of Orthopedics, Harrison International Peace Hospital Hengshui, Hebei, China.
Xinhu ZhangThird Department of Orthopedics, Harrison International Peace Hospital Hengshui, Hebei, China.
Lianjun ZhouThird Department of Orthopedics, Harrison International Peace Hospital Hengshui, Hebei, China.
Jutao PangThird Department of Orthopedics, Harrison International Peace Hospital Hengshui, Hebei, China.
Harrison International Peace Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteosarcoma is one of the first two cause of cancer-related death in children and young adolescents. Inhibitor of Growth 4 (ING4) is a member of the ING tumor suppressor family and play an important role in many cellular processes. The purpose of this study was to explore the correlation between

methods

resultsDown-regulated expression of

conclusionTaken together,

Indexed as

ING4osteosarcomaprognosis

Identifiers

PMID31966890
PMCPMC6965907
OpenAlexW3002310438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.